OBJECTIVE: To investigate the correlation between total and bioavailable serum 25-OH vitamin D and the pregnancy rate in recipients of donated oocytes. DESIGN: Retrospective study. SETTING: University-affiliated private IVF center. PATIENT(S): A total of 267 patients who were referred to our clinic for oocyte donation from June 2013 to December 2013. INTERVENTION(S): Serum analysis of vitamin D and bioavailable vitamin D and reproductive outcomes. MAIN OUTCOME MEASURE(S): Pregnancy and implantation rate. RESULT(S): Among all patients, 15.3% (n = 41) were vitamin D replete (vitamin D >30 ng/mL), 50.2% (n = 134) had vitamin D deficiency (20-30 ng/mL), and 34.4% (n = 92) had insufficient vitamin D (<20 ng/mL). Implantation rates were similar among patients with normal, insufficient, or deficient total serum 25-OH vitamin D levels (61%, 63.4%, and 65.2%, respectively). Pregnancy rates did not differ among the three groups (70%, 69.9%, and 73.9%). Ongoing pregnancy rates were also comparable among the three groups (55.9%, 52.7%, and 60.7%). The predictive value of total vitamin D regarding pregnancy rate was analyzed by the receiver operating characteristic curve, and the area under the curve (AUC) was 0.468. The AUC for bioavailable 25-OH vitamin D was 0.499, showing that the analysis of the AUC for vitamin D or bioavailable vitamin D was not informative. CONCLUSION(S): Vitamin D insufficiency and deficiency are frequent conditions in our southern European infertile population. In contrast to previous studies, patients who are not vitamin D replete do not have a decreased chance of becoming pregnant with egg donation. Bioavailable 25-OH vitamin D, which is a better marker of the status than total 25-OH vitamin D, does not correlate with pregnancy rate in recipients of donated oocytes. Thus, at this stage, there is insufficient evidence to recommend vitamin D screening in patients undergoing egg donation.
OBJECTIVE: To investigate the correlation between total and bioavailable serum 25-OH vitamin D and the pregnancy rate in recipients of donated oocytes. DESIGN: Retrospective study. SETTING: University-affiliated private IVF center. PATIENT(S): A total of 267 patients who were referred to our clinic for oocyte donation from June 2013 to December 2013. INTERVENTION(S): Serum analysis of vitamin D and bioavailable vitamin D and reproductive outcomes. MAIN OUTCOME MEASURE(S): Pregnancy and implantation rate. RESULT(S): Among all patients, 15.3% (n = 41) were vitamin D replete (vitamin D >30 ng/mL), 50.2% (n = 134) had vitamin D deficiency (20-30 ng/mL), and 34.4% (n = 92) had insufficientvitamin D (<20 ng/mL). Implantation rates were similar among patients with normal, insufficient, or deficient total serum 25-OH vitamin D levels (61%, 63.4%, and 65.2%, respectively). Pregnancy rates did not differ among the three groups (70%, 69.9%, and 73.9%). Ongoing pregnancy rates were also comparable among the three groups (55.9%, 52.7%, and 60.7%). The predictive value of total vitamin D regarding pregnancy rate was analyzed by the receiver operating characteristic curve, and the area under the curve (AUC) was 0.468. The AUC for bioavailable 25-OH vitamin D was 0.499, showing that the analysis of the AUC for vitamin D or bioavailable vitamin D was not informative. CONCLUSION(S): Vitamin Dinsufficiency and deficiency are frequent conditions in our southern European infertile population. In contrast to previous studies, patients who are not vitamin D replete do not have a decreased chance of becoming pregnant with egg donation. Bioavailable 25-OH vitamin D, which is a better marker of the status than total 25-OH vitamin D, does not correlate with pregnancy rate in recipients of donated oocytes. Thus, at this stage, there is insufficient evidence to recommend vitamin D screening in patients undergoing egg donation.
Authors: Lubna Pal; Heping Zhang; Joanne Williams; Nanette F Santoro; Michael P Diamond; William D Schlaff; Christos Coutifaris; Sandra A Carson; Michael P Steinkampf; Bruce R Carr; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Evan Myers; Richard S Legro Journal: J Clin Endocrinol Metab Date: 2016-05-17 Impact factor: 5.958